CBD, CBG, and CBN are three distinct non-psychoactive (or mildly psychoactive in CBN’s case) hemp cannabinoids with different mechanisms and therapeutic targets. CBD (cannabidiol) is the most studied, acting on multiple receptor systems to produce anxiety reduction, anti-inflammatory effects, and anticonvulsant activity. CBG (cannabigerol) is the “stem cell” cannabinoid that all other cannabinoids are synthesized from in the plant, with emerging evidence for focus and anti-inflammatory effects. CBN (cannabinol) is an oxidation product of THC that produces mild sedation at higher doses and is primarily marketed for sleep. None of these compounds cause psychoactive intoxication at typical doses.

What does CBD actually do?

CBD acts on multiple molecular targets: it antagonizes CB1 receptors (reducing some THC effects when taken together), modulates TRP channels (pain and inflammation), inhibits fatty acid amide hydrolase (FAAH, which breaks down the endocannabinoid anandamide), agonizes 5-HT1A serotonin receptors (anxiolytic mechanism), and interacts with PPAR-gamma nuclear receptors (anti-inflammatory). This multi-target profile explains CBD’s breadth of reported effects. The FDA has approved one CBD drug — Epidiolex — for childhood epilepsy, the only cannabis-derived drug with full FDA approval. A 2019 study found CBD significantly reduced anxiety in 79% of participants within the first month of use.

What does CBG do differently from CBD?

CBG acts differently at CB1 and CB2 receptors than CBD — it’s a partial agonist at CB1 and CB2 rather than an antagonist. CBG also inhibits GABA reuptake (mildly anxiolytic and muscle relaxing), blocks alpha-2 adrenergic receptors (potentially wake-promoting), and has strong antibacterial activity against MRSA in vitro. Users report CBG as more “energizing” than CBD — less drowsy, better for daytime use, with focus-enhancing properties. Early research on CBG for inflammatory bowel disease showed promise in rodent models. CBG is rarer in the plant (under 1% in most cannabis) and more expensive to extract, which is why CBG products carry higher price tags than CBD.

What does CBN do for sleep?

CBN is THC that has been oxidized (exposed to air and light over time), losing potency but gaining mild sedative properties. Contrary to popular marketing, there is very limited human clinical evidence supporting CBN as a sleep aid on its own. A 2021 study found CBN had minimal effect on sleep parameters when isolated. However, combinations of CBD + CBN appear more effective than either alone for sleep. CBN’s mild CB1 agonism may contribute to the sedating effect of aged cannabis products, but CBN alone at typical supplement doses (5–10mg) likely produces minimal sedation for most people. Its sleep reputation is partly based on the sedating effects of old, THC-degraded cannabis.

How do these cannabinoids interact with each other?

The “entourage effect” describes the theory that cannabinoids, terpenes, and other plant compounds work better together than in isolation. HiXotic D9/CBD 15:10 Gummies at Elevated Haze use a 15:10 CBD-to-Delta-9 ratio deliberately — CBD modulates and moderates the THC experience, reducing paranoia and extending duration while softening peak intensity. Full-spectrum hemp products (containing CBD, CBG, CBN, trace THC, and terpenes) consistently outperform CBD isolate in anxiety and sleep studies, supporting the entourage effect hypothesis. For consumers: broad-spectrum or full-spectrum products likely provide better total outcomes than single-cannabinoid products.